Skip to Content
Merck
CN
  • Generation of human induced pluripotent stem cell lines from patients with selective IgA deficiency.

Generation of human induced pluripotent stem cell lines from patients with selective IgA deficiency.

Stem cell research (2019-11-07)
Jonathan Arias-Fuenzalida, Jingwei Yu, Likun Du, Joaquin Custodio, Luigi D Notarangelo, Lennart Hammarström, Qiang Pan-Hammarström
ABSTRACT

Selective immunoglobulin-A deficiency (IgAD) is the most common primary immunodeficiency (PID) in the Western world and results in higher susceptibility to infections, autoimmune disorders and malignancies. We generated human induced pluripotent stem cell lines from two patients with selective IgAD, PHAi001 and PHAi002. Patient samples were reprogrammed using non-integrative based methods. Pluripotency of the PHAi001 and PHAi002 cell lines was confirmed by their expression of stem cell markers and capacity to differentiate into cells of the three germ layers. The PHAi001 and PHAi002 lines are a unique resource for experimental modeling of selective IgAD and associated disorders.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Y-27632 dihydrochloride, ≥98% (HPLC)